ZEISS Medical Technology announced that the National Medical Products Administration (NMPA) in China has approved the VISUMAX® 800 with SMILE® pro software from ZEISS for surgically treating nearsightedness, with or without astigmatism.
ABANZA, a leader in advanced soft tissue repair solutions, is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its innovative WasherCap™ Mini fixation system. This breakthrough device is designed for multiple applications, including meniscal root repair and ACL reconstruction.
Tandem Diabetes Care, Inc. a leading insulin delivery and diabetes technology company, announced that its next-generation automated insulin delivery (AID) algorithm, Control-IQ+ technology (Control-IQ+), has been cleared by the United State.
VetSnap, the leading digital logbook solution for controlled drug compliance, and Vaultek, a premier manufacturer of high-performance smart safes, have announced a partnership for hardware and logbook integration that enhances security and streamlines compliance processes for veterinary practices handling controlled substances.
BodyBio, a leader in cellular health solutions, announced the launch of ReMineralize, an innovative ionic mineral supplement designed to optimize cellular function through comprehensive mineral replenishment. This groundbreaking product delivers over 72 naturally occurring trace minerals in their most bioavailable form, setting a new standard in mineral supplementation.
BD (Becton, a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.
Lunit a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the publication of a new study in the Journal of Clinical Oncology Precision Oncology. Conducted in collaboration with Japan's National Cancer Center Hospital East (NCCHE).
Centinel Spine®, LLC the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced achievement of record fourth quarter and full-year 2024 business results, positioning the Company for continued accelerated growth in 2025.
The CVS Health® Foundation announced $4 million in grants over five years as part of its new Healthy Aging initiative to support Atlanta Regional Collaborative for Health Improvement in Atlanta, GA, Center for Better Aging in Chicago, IL, EngageWell.
ZEISS Medical Technology announced today that the MEL® 90 received approval from the U.S. Food and Drug Administration (FDA), giving the excimer laser technology simultaneous approval for all three major indications, including myopia, hyperopia and mixed astigmatism (a condition where both hyperopic and myopic correction is required).